amberen
Small moleculeexperimental
Succinic acid is a dicarboxylic acid with the chemical formula (CH2)2(CO2H)2. In living organisms, succinic acid takes the form of an anion, succinate, which has multiple biological roles as a metabolic intermediate being converted into fumarate by the enzyme succinate dehydrogenase in complex 2 of the electron transport chain which is involved in making ATP, and as a signaling molecule reflecting the cellular metabolic state. — Wikipedia
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Apr 24, 2017 (NCT03118908)
Timeline
No events for the selected filters.
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaSuccinic acid ↗
Also known as
- amberen
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03897738 | N/A | Apr 30, 2019 | I.M. Sechenov First Moscow State Medical University |
| NCT03118908 | N/A | Apr 24, 2017 | I.M. Sechenov First Moscow State Medical University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| I.M. Sechenov First Moscow State Medical University | Academic/Hospital | 2 | 2 | 1 | 2017 |
1 organizations
Page 1 / 1